# Treatment of Obesity With Topiramate in Patients With Polycystic Ovary Syndrome

> **NCT04453306** · PHASE4 · UNKNOWN · sponsor: **Hospital de Clinicas de Porto Alegre** · enrollment: 80 (estimated)

## Conditions studied

- Obesity
- Polycystic Ovary Syndrome
- Hyperandrogenism

## Interventions

- **DRUG:** Topiramate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04453306
- **Lead sponsor:** Hospital de Clinicas de Porto Alegre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-05
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2020-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04453306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04453306, "Treatment of Obesity With Topiramate in Patients With Polycystic Ovary Syndrome". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04453306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*